phosa.eu
Pherecydes Pharma
http://www.phosa.eu/pherecydes-pharma.html
PHOSA : objectifs et résultats attendus. 21/11/2016 - Colloque Phages on MARSeille : Avec la participation d’Alain Dublanchet et Olivier Patey (CHIV). - - - - - - - - - - - - - - - - - -. 05/09/2016 - Reportage sur France Culture : Avec une interview de Guy-Charles de La Horie, Cindy Fevre et Mathieu Médina (Pherecydes). - - - - - - - - - - - - - - - - - -. Créée en 2006, Pherecydes Pharma. Romainville, 93) est le seul acteur industriel français à développer des solutions fondées sur la phagothérapie.
pherecydes-pharma.com
- Pherecydes Pharma
http://www.pherecydes-pharma.com/theranostic.html
A world first: Pherecydes Pharma launches multicenter clinical study of phage therapy in serious bur. For the first time, an industry-standard clinical trial is evaluating the tolerance and effectiveness of phages in fighting sensitive antibiotic-resistant infections. This article was published in the journal Annals of Burn and Fire Disasters, 2015; 23(1):13-20. French Documentary on FUTUR MAG - ARTE. Article in LesEchos.fr. PHERECYDES PHARMA 2009 - Legal.
pherecydes-pharma.com
Antibiotic resistance - Pherecydes Pharma
http://www.pherecydes-pharma.com/a-rising-threat.html
A world first: Pherecydes Pharma launches multicenter clinical study of phage therapy in serious bur. For the first time, an industry-standard clinical trial is evaluating the tolerance and effectiveness of phages in fighting sensitive antibiotic-resistant infections. This article was published in the journal Annals of Burn and Fire Disasters, 2015; 23(1):13-20. French Documentary on FUTUR MAG - ARTE. Article in LesEchos.fr. Species, other gram negative pathogens such as. Originally ESBL-producing bacter...
pherecydes-pharma.com
Development - Pherecydes Pharma
http://www.pherecydes-pharma.com/pipeline.html
A world first: Pherecydes Pharma launches multicenter clinical study of phage therapy in serious bur. For the first time, an industry-standard clinical trial is evaluating the tolerance and effectiveness of phages in fighting sensitive antibiotic-resistant infections. This article was published in the journal Annals of Burn and Fire Disasters, 2015; 23(1):13-20. French Documentary on FUTUR MAG - ARTE. Article in LesEchos.fr. Our scientists also work on. And Staphylococcus. These three species alone a...
pherecydes-pharma.com
Pherecydes Pharma
http://www.pherecydes-pharma.com/home.html
A world first: Pherecydes Pharma launches multicenter clinical study of phage therapy in serious bur. For the first time, an industry-standard clinical trial is evaluating the tolerance and effectiveness of phages in fighting sensitive antibiotic-resistant infections. This article was published in the journal Annals of Burn and Fire Disasters, 2015; 23(1):13-20. Innovative biotechnologies: bacteriophages against infections. Increasing Resistance is a natural phenomenon. Killing 63,000 patients. The resis...
pherecydes-pharma.com
Phage Partnerships - Pherecydes Pharma
http://www.pherecydes-pharma.com/partnership.html
A world first: Pherecydes Pharma launches multicenter clinical study of phage therapy in serious bur. For the first time, an industry-standard clinical trial is evaluating the tolerance and effectiveness of phages in fighting sensitive antibiotic-resistant infections. This article was published in the journal Annals of Burn and Fire Disasters, 2015; 23(1):13-20. French Documentary on FUTUR MAG - ARTE. Article in LesEchos.fr. PHERECYDES PHARMA 2009 - Legal.
pherecydes-pharma.com
Company information - Pherecydes Pharma
http://www.pherecydes-pharma.com/company-information.html
A world first: Pherecydes Pharma launches multicenter clinical study of phage therapy in serious bur. For the first time, an industry-standard clinical trial is evaluating the tolerance and effectiveness of phages in fighting sensitive antibiotic-resistant infections. This article was published in the journal Annals of Burn and Fire Disasters, 2015; 23(1):13-20. French Documentary on FUTUR MAG - ARTE. Article in LesEchos.fr. 102 avenue Gaston Roussel. 93230 Romainville - France. Phone: 33 (0)1 48 40 65 35.
pherecydes-pharma.com
Psedomonas aeruginosa - Pherecydes Pharma
http://www.pherecydes-pharma.com/pseudomonas-aeruginosaa.html
A world first: Pherecydes Pharma launches multicenter clinical study of phage therapy in serious bur. For the first time, an industry-standard clinical trial is evaluating the tolerance and effectiveness of phages in fighting sensitive antibiotic-resistant infections. This article was published in the journal Annals of Burn and Fire Disasters, 2015; 23(1):13-20. French Documentary on FUTUR MAG - ARTE. Article in LesEchos.fr. Innate and acquired) is. Bacteriophage PNM (a member of the. Family with contrac...
pherecydes-pharma.com
Media - Pherecydes Pharma
http://www.pherecydes-pharma.com/media.html
A world first: Pherecydes Pharma launches multicenter clinical study of phage therapy in serious bur. For the first time, an industry-standard clinical trial is evaluating the tolerance and effectiveness of phages in fighting sensitive antibiotic-resistant infections. This article was published in the journal Annals of Burn and Fire Disasters, 2015; 23(1):13-20. French Documentary on FUTUR MAG - ARTE. Article in LesEchos.fr. For any information related to press and other media, please contact.
pherecydes-pharma.com
Shareholders - Pherecydes Pharma
http://www.pherecydes-pharma.com/shareholders.html
A world first: Pherecydes Pharma launches multicenter clinical study of phage therapy in serious bur. For the first time, an industry-standard clinical trial is evaluating the tolerance and effectiveness of phages in fighting sensitive antibiotic-resistant infections. This article was published in the journal Annals of Burn and Fire Disasters, 2015; 23(1):13-20. French Documentary on FUTUR MAG - ARTE. Article in LesEchos.fr. Fond Sécurité and Financière de Brienne. ACE Management manages seven investment...